GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

RBC Bioscience 6848.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

20.60

0.00%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2024

Revenue

TWD 205.2m

FY2018FY2024

Net income

TWD 21.6m

FY2018FY2024

Free cash flow

TWD 45.6m

FY2018FY2024

Shareholders' equity

TWD 249.3m

FY2018FY2024

Income statement

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018
RevenueTWD 205.2mTWD 172.5mTWD 173.9mTWD 251.2mTWD 575.2mTWD 161.7mTWD 126.0m
Gross profitTWD 98.1mTWD 72.9mTWD 73.0mTWD 117.1mTWD 300.3mTWD 66.9mTWD 57.2m
Research and developmentTWD 9.9mTWD 10.8mTWD 15.7mTWD 16.4mTWD 22.2mTWD 8.8mTWD 7.7m
Operating incomeTWD 35.8mTWD 14.5mTWD 7.8mTWD 48.6mTWD 188.4mTWD 19.5mTWD 14.1m
Net incomeTWD 21.6mTWD 6.4mTWD 3.8mTWD 28.7mTWD 141.9mTWD 14.5mTWD 13.7m
Diluted earnings per share1.640.490.292.3411.801.760.95

Balance sheet

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Total assetsTWD 763.9mTWD 753.8mTWD 790.5mTWD 847.6mTWD 512.6mTWD 201.0mTWD 166.3m
Cash and short-term investmentsTWD 81.1mTWD 65.2mTWD 76.6mTWD 126.5mTWD 184.0mTWD 43.3mTWD 22.6m
Total liabilitiesTWD 514.6mTWD 513.1mTWD 541.7mTWD 590.8mTWD 337.9mTWD 27.2mTWD 80.7m
DebtTWD 478.5mTWD 471.6mTWD 481.7mTWD 511.0mTWD 120.5mTWD 94.8mTWD 48.0m
Shareholders' equityTWD 249.3mTWD 240.7mTWD 248.8mTWD 256.8mTWD 174.7mTWD 87.7mTWD 85.5m
Shares outstanding13m13m13m12m12m8m14m

Cash flow

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operationsTWD 55.9mTWD 13.2mTWD 6.6m−TWD 25.3mTWD 205.7mTWD 40.2mTWD 3.9m
Capital spending−TWD 10.3m−TWD 6.5m−TWD 10.0m−TWD 450.1m−TWD 118.4m−TWD 9.1m−TWD 70.0m
Free cash flowTWD 45.6mTWD 6.7m−TWD 3.4m−TWD 475.4mTWD 87.3mTWD 31.1m−TWD 66.1m
Dividends paid−TWD 13.0m−TWD 14.5m−TWD 11.8m−TWD 14.4m−TWD 54.8m−TWD 12.3m—

Latest quarters

By quarter end

Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022Jun 2022Dec 2021
RevenueTWD 107.7mTWD 94.2mTWD 111.1mTWD 83.5mTWD 88.9mTWD 71.6mTWD 102.3mTWD 125.6m
Gross profitTWD 50.5mTWD 42.5mTWD 51.6mTWD 36.7mTWD 36.2mTWD 27.1mTWD 45.9mTWD 58.5m
Operating incomeTWD 18.5mTWD 14.4mTWD 20.9mTWD 8.3mTWD 6.3m−TWD 3.8mTWD 16.1mTWD 21.2m
Net incomeTWD 11.2mTWD 8.4mTWD 13.1mTWD 4.1mTWD 2.3m−TWD 4.7mTWD 8.5mTWD 14.4m
Diluted earnings per share0.860.641.000.320.18-0.360.661.17
Cash from operationsTWD 8.0mTWD 30.0mTWD 25.0mTWD 19.0m−TWD 6.0m—TWD 7.0m−TWD 12.0m
Capital spending−TWD 8.0m−TWD 1.0m−TWD 3.0m−TWD 3.0m−TWD 1.0m−TWD 3.0m−TWD 5.0m−TWD 225.0m
Free cash flowTWD 0TWD 29.0mTWD 22.0mTWD 16.0m−TWD 7.0m—TWD 2.0m−TWD 237.0m
Total assetsTWD 757.6mTWD 763.9mTWD 771.7mTWD 753.8mTWD 763.2mTWD 790.5m—TWD 847.6m
Cash and short-term investmentsTWD 61.0mTWD 81.1mTWD 76.7mTWD 65.9mTWD 67.0mTWD 76.6m—TWD 126.5m
DebtTWD 436.2mTWD 477.6mTWD 460.9mTWD 74.8mTWD 47.1mTWD 64.5m—TWD 68.7m
Shareholders' equityTWD 260.5mTWD 249.3mTWD 248.1mTWD 240.7mTWD 236.6mTWD 248.8m—TWD 256.8m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-6.5%4.9%—
Operating income-9.7%12.9%—
Net income-9.1%8.3%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin45.3%45.0%47.3%—
Operating margin13.3%13.3%20.4%—
Net margin7.4%7.5%14.1%—

Valuation history

At each fiscal year end

FY2024FY2023FY2022FY2021
Price to earnings10.629.649.513.6
Price to sales1.11.11.11.6

Dividends and splits

Per share, in the currency the company pays

Paid for 4 years. Last went ex-dividend on 2 Oct 2025.

FY2025FY2024FY2023FY2022
Paid in the year0.300.9091.0180.909
  • 1100-for-1000 split · 11 Aug 2025
  • 1100-for-1000 split · 8 Aug 2025
  • 1100-for-1000 split · 21 Jul 2022

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.